In contrast, few apoptotic cells were appreciable in the few residual HCC lesions from c-MYC/Mcl1 mice treated for 3 weeks with the combination therapy (Supplemental Figure 16, middle panel). This evidence concerns the gene MYC and hepatocellular carcinoma.